Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications
Patients with melanoma or NSCLC under ICI treatment can develop clinical irAEs, immune-related PET findings, or both. The occurrence of immune-related events has a prognostic impact. Combining clinical information with PET assessment improved outcome stratification.
Authors
- Antonino Restuccia
- Teresa Del Giudice
- Francesco Cicone (ORCID: https://orcid.org/0000-0003-4664-1965)
- Maria Cucè
- Giuseppe Lucio Cascini (ORCID: https://orcid.org/0000-0003-0332-2606)
- Giulia Santo (ORCID: https://orcid.org/0000-0001-6565-0686)
- Pierfrancesco Tassone (ORCID: https://orcid.org/0000-0002-8298-6787)
- Pierosandro Tagliaferri
Institutions
- Magna Graecia University (IT)
- Azienda Ospedaliero-Universitaria "Renato Dulbecco" (IT)
- Azienda Ospedaliera Pugliese Ciaccio (IT)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1186/s40644-024-00774-9
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57